Earnings Preview: PTC Therapeutics
Portfolio Pulse from Benzinga Insights
PTC Therapeutics (NASDAQ:PTCT) is scheduled to release its quarterly earnings report on Thursday, 2024-02-29, with an estimated EPS of $0.50. Historical performance shows significant price changes following earnings announcements, with a notable 22.71% drop after last quarter's miss. Shares are currently trading at $28.31, down 36.73% over the last year, indicating potential investor concern ahead of the earnings release.
February 28, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
PTC Therapeutics is expected to report an EPS of $0.50 for the upcoming earnings, with historical data showing significant stock price volatility post-earnings. The stock has seen a 36.73% decline over the past year, indicating potential investor concern.
Given PTCT's history of significant price movements post-earnings and the current downward trend in its stock price, the upcoming earnings report could maintain the stock's volatility. However, the exact direction will heavily depend on whether PTCT meets or exceeds the EPS estimate and the future guidance provided.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100